NATUREX : Naturex announces Olivier Rigaud’s appointment as Chief Executive Officer


Avignon, 21 July 2014 - Naturex, the global leader in specialty plant-based natural ingredients, informs its shareholders that its senior management has been reinforced by the appointment of Mr. Olivier Rigaud as Chief Executive Officer.

With a degree in Chemistry, Olivier Rigaud, 50 years old, began his career with Amylum (starch) in 1988, subsequently acquired by Tate & Lyle, a British-based multinational and global provider of ingredients for the agribusiness industry, and has served as President of its Speciality Food Ingredients division since 2010. With 26 years of experience in the field of ingredients both within a medium-sized company as well as in a group with an international dimension, Olivier Rigaud stands out as a person of value who will be capable of leading the development of Naturex with passion and energy.

For that reason, on the proposal of its Chairman and following the favourable opinion issued by the Nominating and Compensation Committee, the Company's Board of Directors decided to strengthen the company's senior management through this major appointment.

Thierry Lambert, Chairman of the Board of Directors, will assist Olivier Rigaud in fulfilling his new functions, commencing in the fall and will continue to occupy an executive role in spearheading the company and its strategy.

"It is with great pleasure and satisfaction that I welcome Olivier Rigaud as Naturex's Chief Executive Officer. His recognised knowledge of our business and his qualities as a person make him an ideal candidate and I am very much looking forward to working with him as a team in pursuing Naturex's development", commented Thierry Lambert, Chairman of the Board of Directors.

Olivier Rigaud added: "I am delighted and proud of having been given this opportunity to join Naturex, an international group that has already achieved a number of successes and that continues to pursue ambitious goals, and I am looking forward to contributing to its future successes in this new role."

You can receive all financial information of Naturex free of charge by signing up at:

Financial schedule

- 2014 H1 sales
- 2014 first-half results
25 July 2014
29 August 2014

Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B

Total number of shares comprising the share capital: 9,182,307
ISIN FR0000054694

NATUREX is a component of the CAC PEA-PME, CAC Small, Gaïa Index.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD).

TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

About Naturex

Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.

Thierry Lambert
Chairman and Chief Executive Officer
Tel.: +33 (0)4 90 23 96 89
Thierry-Bertrand Lambert
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93

Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués
Communiqué intégral et original au format PDF :

Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.

Pour consulter le fichier PDF en intégralité, cliquez ici.

Pour visualiser les documents au format PDF, vous pouvez télécharger gratuitement Acrobat Reader XI.

Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant